680 related articles for article (PubMed ID: 16277573)
1. Immune response: the key to bone resorption in periodontal disease.
Taubman MA; Valverde P; Han X; Kawai T
J Periodontol; 2005 Nov; 76(11 Suppl):2033-41. PubMed ID: 16277573
[TBL] [Abstract][Full Text] [Related]
2. Immune Response: The Key to Bone Resorption in Periodontal Disease.
Taubman MA; Valverde P; Han X; Kawai T
J Periodontol; 2005 Nov; 76 Suppl 11S():2033-2041. PubMed ID: 29539039
[TBL] [Abstract][Full Text] [Related]
3. Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease.
Valverde P; Kawai T; Taubman MA
J Bone Miner Res; 2004 Jan; 19(1):155-64. PubMed ID: 14753747
[TBL] [Abstract][Full Text] [Related]
4. Bacterial-responsive B lymphocytes induce periodontal bone resorption.
Han X; Kawai T; Eastcott JW; Taubman MA
J Immunol; 2006 Jan; 176(1):625-31. PubMed ID: 16365458
[TBL] [Abstract][Full Text] [Related]
5. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection.
Teng YT; Nguyen H; Gao X; Kong YY; Gorczynski RM; Singh B; Ellen RP; Penninger JM
J Clin Invest; 2000 Sep; 106(6):R59-67. PubMed ID: 10995794
[TBL] [Abstract][Full Text] [Related]
6. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
[TBL] [Abstract][Full Text] [Related]
7. The cytolethal distending toxin induces receptor activator of NF-kappaB ligand expression in human gingival fibroblasts and periodontal ligament cells.
Belibasakis GN; Johansson A; Wang Y; Chen C; Kalfas S; Lerner UH
Infect Immun; 2005 Jan; 73(1):342-51. PubMed ID: 15618171
[TBL] [Abstract][Full Text] [Related]
8. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease.
Kawai T; Matsuyama T; Hosokawa Y; Makihira S; Seki M; Karimbux NY; Goncalves RB; Valverde P; Dibart S; Li YP; Miranda LA; Ernst CW; Izumi Y; Taubman MA
Am J Pathol; 2006 Sep; 169(3):987-98. PubMed ID: 16936272
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model.
Kawai T; Paster BJ; Komatsuzawa H; Ernst CW; Goncalves RB; Sasaki H; Ouhara K; Stashenko PP; Sugai M; Taubman MA
Oral Microbiol Immunol; 2007 Jun; 22(3):208-15. PubMed ID: 17488448
[TBL] [Abstract][Full Text] [Related]
10. LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin.
Nagasawa T; Kobayashi H; Kiji M; Aramaki M; Mahanonda R; Kojima T; Murakami Y; Saito M; Morotome Y; Ishikawa I
Clin Exp Immunol; 2002 Nov; 130(2):338-44. PubMed ID: 12390325
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
[TBL] [Abstract][Full Text] [Related]
12. Potassium channel-blockers as therapeutic agents to interfere with bone resorption of periodontal disease.
Valverde P; Kawai T; Taubman MA
J Dent Res; 2005 Jun; 84(6):488-99. PubMed ID: 15914584
[
